Brain tumor magnetic targeting and biodistribution of superparamagnetic iron oxide nanoparticles linked with 70-kDa heat shock protein study by nonlinear longitudinal response

Journal of Magnetism and Magnetic Materials

Volumn 388, Issue , 2015, Pages 123-134

  Shevtsov, Maxim A ^a,b   Nikolaev, Boris P ^c   Ryzhov, Vyacheslav A ^d   Yakovleva, Ludmila Y ^c   Dobrodumov, Anatolii V ^e   Marchenko, Yaroslav Y ^c   Margulis, Boris A ^a   Pitkin, Emil ^f   Guzhova, Irina V ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

^b Polenov Research Institute of Neurosurgery   (Russian Federation)

^c Institute for Highly Pure Biopreparations   (Russian Federation)

^d PETERSBURG NUCLEAR PHYSICS INSTITUTE   (Russian Federation)

^e INSTITUTE OF MACROMOLECULAR COMPOUNDS   (Russian Federation)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

9L glioma; Biodistribution; Brain tumor; Hsp70; Magnetic resonance imaging; Second harmonic nonlinear response; SPION

Indexed keywords

BIOCOMPATIBILITY; BRAIN; CELL CULTURE; MAGNETIC RESONANCE IMAGING; MAGNETISM; MOBILE SECURITY; NANOPARTICLES; PROTEINS; SUPERPARAMAGNETISM; SYNTHESIS (CHEMICAL); TUMORS;

9L GLIOMA; BIODISTRIBUTIONS; BRAIN TUMORS; HSP70; NON-LINEAR RESPONSE; SPION;

NANOMAGNETICS;

EID: 84927599209     PISSN: 03048853     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmmm.2015.04.030     Document Type: Article

References (48)

1. M. Wankhede, A. Bouras, M. Kaluzova, and C.G. Hadjipanayis Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy Expert Rev. Clin. Pharmacol. 5 2012 173 186
2. M. Li, H. Deng, H. Peng, and Q. Wang Functional nanoparticles in targeting glioma diagnosis and therapies J. Nanosci. Nanotechnol. 14 2014 415 432
3. Y.X. Wang Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application Quant. Imaging Med. Surg. 1 2011 35 40
4. J. Guo, X. Gao, L. Su, H. Xia, G. Gu, Z. Pang, X. Jiang, L. Yao, J. Chen, and H. Chen Aptamer-functionalized PEGPLGA nanoparticles for enhanced anti-glioma drug delivery Biomaterials 32 2011 8010 8020
5. C.G. Hadjipanayis, R. Machaidze, M. Kaluzova, L. Wang, A.J. Schuette, H. Chen, X. Wu, and H. Mao EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma Cancer Res. 70 2010 6303 6312
6. Y. Kuang, S. An, Y. Guo, S. Huang, K. Shao, Y. Liu, J. Li, H. Ma, and C. Jiang T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting Int. J. Pharm. 454 2013 11 20
7. B.P. Nikolaev, Y.Y. Marchenko, L.Y. Yakovleva, T.M. Zimina, A.V. Soloviev, V.V. Luchinin, A.V. Petrov, T.A. Scharafutdinova, and A.V. Dobrodumov Magnetic epidermal growth factor for targeted delivery to grafted tumor in mouse model IEEE Trans. Magn. 49 2013 429 435
8. M.A. Shevtsov, B.P. Nikolaev, L.Y. Yakovleva, Y.Y. Marchenko, A.V. Dobrodumov, A.L. Mikhrina, M.G. Martynova, O.A. Bystrova, I.V. Yakovenko, and A.M. Ischenko Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors Int. J. Nanomed. 9 2014 273 287
9. M.A. Shevtsov, L.Y. Yakovleva, B.P. Nikolaev, Y.Y. Marchenko, A.V. Dobrodumov, K.V. Onokhin, Y.S. Onokhina, S.A. Selkov, A.L. Mikhrina, I.V. Guzhova, M.G. Martynova, O.A. Bystrova, A.M. Ischenko, and B.A. Margulis Tumor targeting using magnetic nanoparticle Hsp70 conjugate in a model of C6 glioma Neuro Oncol. 16 2014 38 49
10. M. Mahmoudi, A. Simchi, M. Imani, M.A. Shokrgozar, A.S. Milani, U.O. Häfeli, and P. Stroeve A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles Colloids Surf. B: Biointerfaces 75 2010 300 309
11. A. Chatzigeorgiou, M. Lyberi, G. Chatzilymperis, A. Nezos, and E. Kamper CD40/CD40L signaling and its implication in health and disease Biofactors 35 2009 474 483
12. T. Kim, E. Momin, J. Choi, K. Yuan, H. Zaidi, J. Kim, M. Park, N. Lee, M.T. McMahon, A. Quinones-Hinojosa, J.W. Bulte, T. Hyeon, and A.A. Gilad Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells J. Am. Chem. Soc. 133 2011 2955 2961
13. C.C. Berry, S. Wells, S. Charles, G. Aitchison, and A.S. Curtis Cell response to dextranderivatised iron oxide nanoparticles post internalisation Biomaterials 25 2004 5405 5413
14. U.O. Häfeli, J.S. Riffle, L. Harris-Shekhawat, A. Carmichael-Baranauskas, F. Mark, J.P. Dailey, and D. Bardenstein Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery Mol. Pharm. 6 2009 1417 1428
15. G. Liu, J. Gao, H. Ai, and X. Chen Applications and potential toxicity of magnetic iron oxide nanoparticles Small 9 2013 1533 1545
16. M. Mahmoudi, H. Hofmann, B. Rothen-Rutishauser, and A. Petri-Fink Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles Chem. Rev. 112 2012 2323 2338
17. J.M. Veranth, E.G. Kaser, M.M. Veranth, M. Koch, and G.S. Yost Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts Part. Fibre Toxicol. 4 2007 2
18. R. Weissleder, D.D. Stark, B.L. Engelstad, B.R. Bacon, C.C. Compton, D.L. White, P. Jacobs, and J. Lewis Superparamagnetic iron oxide: pharmacokinetics and toxicity AJR Am. J. Roentgenol. 152 1989 167 173
19. G.K. Anisimov, R.P. Devyaterikov, E.I. Zavatzii, V.V. Lavrov, V.A. Ryzhov, D.M. Fel'dman, and V.N. Fomichev Investigation of paramagnetic substances by using nonlinear effects in paramagnets in parallel magnetic fields Sov. Phys. Tech. Phys. 27 1982 46 50
20. V.A. Ryzhov, I.I. Larionov, and V.N. Fomichev On the spurious signal in the longitudinal nonlinear susceptibility of magnets at the second harmonic of excitation frequency Tech. Phys. 41 1996 620 626
21. V.A. Ryzhov, E.I. Zavatskii, Patent No. 2507525, registered in Russia 20.02.14.
22. I.V. Guzhova, V.F. Lazarev, A.V. Kaznacheeva, M.V. Ippolitova, V.I. Muronetz, A.V. Kinev, and B.A. Margulis Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease Hum. Mol. Genet. 20 2011 3953 3963
23. R. Massart Preparation of aqueous magnetic liquids in alkaline and acidic media IEEE Trans. Magn. 1 1981 1247 1248
24. V.A. Ryzhov, I.V. Pleshakov, A.A. Nechitailov, N.V. Glebova, E.N. Pyatyshev, A.V. Malkova, I.A. Kiselev, and V.V. Matveev Magnetic study of nanostructural composite material based on cobalt compounds and porous silicon Appl. Magn. Resonan. 45 2014 339 352
25. B.D. Gullity, and C.D. Graham Introduction to Magnetic Materials 2009 IEEE Press, Wiley New York
26. S. Bedanta, and W. Kleemann J. Phys. D: Appl. Phys. 42 2009 013001
27. B. Gleich, and J. Weizenecker Tomographic imaging using the nonlinear response of magnetic particles Nature 435 2005 1214 1217
28. M.H. Pablico-Lansigan, S.F. Situ, and A.C.S. Samia Magnetic particle imaging: advancements and perspectives for real-time in vivo monitoring and image-guided therapy Nanoscale 5 2013 4040 4055
29. A.V. Lazuta, I.I. Larionov, and V.A. Ryzhov Second-harmonic nonlinear response of a cubic ferromagnet in the critical paramagnetic neighborhood of TC Sov. Phys. JETP 73 1991 1086 1095
30. V.A. Ryzhov, A.V. Lazuta, I.D. Luzyanin, I.I. Larionov, V.P. Khavronin, Yu.P. Chernenkov, I.O. Troyanchuk, and D.D. Khalyavin. The nonlinear magnetic properties of the pseudocubic Nd0.77Ba0.23MnO3 single crystal in the critical paramagnetic region and phase separation J. Exp. Theor. Phys. 94 2002 581 592
31. V.A. Ryzhov, A.V. Lazuta, P.I. Molkanov, V.P. Khavronin, A.I. Kurbakov, V.V. Runov, Ya.M. Mukovskii, A.E. Pestun, and R.V. Privezentsev Comparative study of heterogeneous magnetic state above TC in La0.82Sr0.18CoO3 cobaltite and La0.83Sr0.17MnO3 manganite J. Magn. Magn. Mater. 324 2012 3432 3436
32. G.F. Goya, T.S. Berquo, F.C. Fonseca, and M.P. Morales J. Appl. Phys. 94 2003 3520
33. A. Aharony Phys. Rev. 177 1969 793 796
34. D.A. Garanin Phys.Rev. E 54 1996 3250 3256
35. Ya Yu Marchenko, A.N. Shishkin, L. Yu Yakovleva, B.P. Nikolaev, Proton relaxivity study of heat shock proteins: magnetic Hsp70 conjugate as potential MRI contrast agent, International Symposium and Summer School in Saint Petersburg: Nuclear Magnetic Resonance in Condensed Matter, 9th meeting on NMR in Heterogeneous Systems, Saint-Petersburg, 9-13 July 2014, p.103.
36. P.W. Lee, S.H. Hsu, J.J. Wang, J.S. Tsai, K.J. Lin, S.P. Wey, F.R. Chen, C.H. Lai, T.C. Yen, and H.W. Sung The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles Biomaterials 31 2010 1316 1324
37. M. Bellusci, A. La Barbera, F. Padella, M. Mancuso, A. Pasquo, M.G. Grollino, G. Leter, E. Nardi, C. Cremisini, P. Giardullo, and F. Pacchierotti Biodistribution and acute toxicity of a nanofluid containing manganese iron oxide nanoparticles produced by a mechanochemical process Int. J. Nanomed. 9 2014 1919 1929
38. A.J. Cole, A.E. David, J. Wang, C.J. Galbán, and V.C. Yang Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles Biomaterials 32 2011 6291 6301
39. L.L. Estevanato, L.M. Lacava, L.C. Carvalho, R.B. Azevedo, O. Silva, F. Pelegrini, S.N. Báo, P.C. Morais, and Z.G. Lacava Long-term biodistribution and biocompatibility investigation of dextran-coated magnetite nanoparticle using mice as the animal model J. Biomed. Nanotechnol. 8 2012 301 308
40. S. Yin, Z. Li, L. Cheng, C. Wang, Y. Liu, Q. Chen, H. Gong, L. Guo, Y. Li, and Z. Liu Magnetic PEGylated Pt3Co nanoparticles as a novel MR contrast agent: in vivo MR imaging and long-term toxicity study Nanoscale 5 2013 12464 12473
41. C. Leten, T. Struys, T. Dresselaers, and U. Himmelreich In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models J. Neurooncol. 119 2014 297 306 (Epub ahead of print) PubMed PMID: 24990826
42. S. Watkins, S. Robel, I.F. Kimbrough, S.M. Robert, G. Ellis-Davies, and H. Sontheimer Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells Nat. Commun. 5 2014 4196
43. C. Zhan, and W. Lu The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery Curr. Pharm. Biotechnol. 13 2012 2380 2387
44. Z. Li, Y.H. Liu, Y.X. Xue, L.B. Liu, and H. Xie Mechanisms for endothelial monocyteactivating polypeptide-II-induced opening of the blood-tumor barrier J. Mol. Neurosci. 47 2012 408 417
45. E.K. Nduom, C. Yang, M.J. Merrill, Z. Zhuang, and R.R. Lonser Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms J. Neurosurg. 119 2013 427 433
46. E.R. O'Brien, C. Howarth, and N.R. Sibson The role of astrocytes in CNS tumors: preclinical models and novel imaging approaches Front. Cell Neurosci. 7 2013 40
47. M.A. Shevtsov, S.V. Shatik, A.V. Tokarev, M.I. Mostova, L.A. Tiutin, N.V. Bychkova, A.L. Mikhrina, K.V. Onokhin, D.A. Meshalkina, I.V. Romanova, O.N. Savchenko, A.A. Ivanova, S.V. Abkin, V.A. Kharatian, I.V. Guzhova, and B.A. Margulis Biodistribution of the recombinant heat shock protein rhHsp70 in intracranial C6 glioma models in Wistar rats and subcutaneos B16/F10 melanoma in C57BL/6 mice Vopr. Onkol. 59 2013 78 83
48. U. Schnonbeck, and P. Libby The CD40/CD154 receptor/ligand dyad Cell Mol. Life Sci. 58 2001 4 43